tirzepatide weight loss clinical trial results surmount-1 Reduction of prevalence of patients meeting the criteria for Tirzepatide for Medical Weight Loss

This is not normal

Tirzepatide (Zepbound) Tirzepatide is also a GLP-1 medication approved for weight loss

These currently include: Orlistat available on NHS prescription and over the counter Semaglutide (Wegovy) authorised by the MHRA for weight management in adults with obesity or overweight with at least one weight-related comorbidity, and recommended by NICE for use within specialist weight management services (NICE technology appraisal TA875) Tirzepatide (Mounjaro) authorised by the MHRA for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, and recommended by NICE for use within specialist weight management services (NICE technology appraisal TA1026) Patients interested in emerging treatments such as retatrutide may wish to discuss their options with their GP or a specialist in obesity medicine

A., Mahns, D

This is about biology